326 results on '"Lefranc, Florence"'
Search Results
2. BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors
3. Late-line treatment with bevacizumab alone or in combination with chemotherapy in recurrent high-grade gliomas
4. Embolization before Gamma Knife radiosurgery for cerebral arteriovenous malformations does not negatively impact its obliteration rate: a series of 190 patients
5. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
6. Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor
7. Recurrent glioblastomas: Should we operate a second and even a third time?
8. Marine-Derived Leads as Anticancer Candidates by Disrupting Hypoxic Signaling through Hypoxia-Inducible Factors Inhibition.
9. Have lichenized fungi delivered promising anticancer small molecules?
10. Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion
11. 5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells
12. EANO guidelines for the diagnosis and treatment of meningiomas
13. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
14. Association of antidepressant drug use with outcome of patients with glioblastoma
15. 4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K+-ATPase and Ras oncogene activity in cancer cells
16. Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase
17. N-Aryl-N′-(chroman-4-yl)ureas and thioureas display in vitro anticancer activity and selectivity on apoptosis-resistant glioblastoma cells: Screening, synthesis of simplified derivatives, and structure–activity relationship analysis
18. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).
19. Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli
20. Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
21. Comprehensive Functional Mapping Scheme for Non-Invasive Primary Sensorimotor Cortex Mapping
22. Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
23. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
24. Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas
25. Endovascular treatment of proximal anterior cerebral artery aneurysms
26. Balloon-assisted coiling of intracranial aneurysms is not associated with a higher complication rate
27. Circumferential and fusiform intracranial aneurysms: reconstructive endovascular treatment with self-expandable stents
28. Endovascular treatment of middle cerebral artery aneurysms
29. Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
30. Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey.
31. FDG-PET as a Prognostic Factor in High-grade Astrocytoma
32. Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release
33. Chondroma of the dural convexity: A case report and literature review
34. Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas?
35. Galectin-1 and immunotherapy for brain cancer
36. Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model
37. Galectins and Gliomas
38. Galectin-1 Is Implicated in the Protein Kinase C ε/Vimentin-Controlled Trafficking of Integrin-β1 in Glioblastoma Cells
39. Targeted therapy of glioblastomas: a 5-year view
40. Caveolin 1 Expression Independently Predicts Shorter Survival in Oligodendrogliomas
41. Evidence of galectin-1 involvement in glioma chemoresistance
42. Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
43. Galectin-1: a small protein with major functions
44. Present and potential future issues in glioblastoma treatment
45. Monitoring the Expression Profiles of Integrins and Adhesion/Growth-regulatory Galectins in Adamantinomatous Craniopharyngiomas: Their Ability to Regulate Tumor Adhesiveness to Surrounding Tissue and Their Contribution to Prognosis
46. Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis
47. EANO guideline on the diagnosis and management of meningiomas.
48. Intracranial tuberculoma: is diffusion-weighted imaging useful in the diagnosis?
49. Characterization of Gastrin-induced Cytostatic Effect on Cell Proliferation in Experimental Malignant Gliomas
50. Galectin-1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.